Quantum Biopharma Ltd.
QNTM · Pharmaceutical Preparations
Latest available SEC filing: 20-F ·
Latest disclosures
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form 20-F/A
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001771885 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- QNTM on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1 Adelaide Street East, Suite 801, Toronto, M5C 2V9
- Incorporated in
- Ontario, Canada
- Fiscal year end
- 31 December
- Former names on EDGAR
- FSD Pharma Inc. (to 15 Aug 2024)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields